No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
656 |
4. Check minimum number of eventsNone |
656 |
5. Include endpointsNone |
656 |
6. Filter based on genotype QC (FinnGen only) |
626 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Optic atrophy
based on the number of shared cases.
Similar with more cases:
- Optic atrophy
- Other disorders of optic [2nd] nerve and visual pathways
- Disorders of optic nerve and visual pathways
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 626 | 345 | 281 |
| Unadjusted period prevalence (%) | 0.13 | 0.12 | 0.13 |
| Median age at first event (years) | 55.58 | 55.09 | 56.17 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 656
- Matched controls
- 6560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H47.2
ICD-10 Finland
Optic atrophy
+∞
307.7
656
*
XCK00
NOMESCO Finland
Perimetry
21.1
283.1
249
185
H53.4
ICD-10 Finland
Visual field defects
28.9
176.4
123
52
CS494
NOMESCO Finland
Other visual field testing
22.4
144.5
111
59
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
9.5
139.1
199
288
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
18.1
130.3
111
73
H46
ICD-10 Finland
Optic neuritis
40.8
123.6
76
21
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
41.8
116.3
71
19
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
51.6
105.2
61
13
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
32.3
102.0
67
23
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
12.5
92.6
97
90
G35
ICD-10 Finland
Multiple sclerosis
23.6
92.3
68
32
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
8.5
90.6
131
187
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
28.6
87.8
60
23
H47.1
ICD-10 Finland
Papilloedema, unspecified
35.2
81.5
52
16
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
5.9
76.4
163
346
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.6
74.4
246
753
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.8
73.9
163
356
XCD10
NOMESCO Finland
Electrophysiological examination of eye
13.1
72.4
72
61
109
Kela drug reimbursment
Multiple sclerosis
27.8
71.2
49
19
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.4
66.8
106
166
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
25.5
60.6
43
18
XCK10
NOMESCO Finland
Photography of fundus of eye
5.1
57.2
139
326
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
96.0
55.9
61
7
N03AX14
ATC
levetiracetam; systemic
10.3
55.1
64
68
101
Kela drug reimbursment
Anterior pituitary hypofunction
20.3
54.0
42
22
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.8
52.1
137
342
TAB00
NOMESCO Finland
Lumbar puncture
6.6
51.3
89
152
Z3229
NOMESCO Finland
Other healthcare associate professional
4.9
51.1
131
320
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
10.7
50.5
57
58
AA1AD
NOMESCO Finland
CT of head and brain
3.4
47.7
263
1091
H02AB09
ATC
hydrocortisone; systemic
8.9
45.6
59
72
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
16.7
41.2
35
22
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
16.7
41.2
35
22
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
11.2
40.6
44
42
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
9.4
39.8
49
56
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
9.5
39.4
48
54
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
53.5
38.1
45
9
N86
ICPC
Multiple sclerosis
55.9
35.8
42
8
E23.00
ICD-10 Finland
Panhypopituitarism
82.9
35.2
39
5
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.3
33.9
96
250
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.2
31.5
56
97
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
8.3
30.6
41
52
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
30.1
27.9
37
13
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.7
27.8
40
55
XA800
NOMESCO Finland
Neuropsychological investigation
4.7
27.8
68
157
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.5
26.7
70
171
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
29.8
25.6
34
12
N03AF02
ATC
oxcarbazepine; oral
5.3
24.1
50
100
SPAT1229
SPAT
Assessment of need for aid
3.8
23.9
78
224
H47.3
ICD-10 Finland
Other disorders of optic disc
37.8
23.2
29
8
N03AG01
ATC
valproic acid; systemic, rectal
3.9
23.0
73
205
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
21.6
22.8
33
16
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
30.3
22.0
29
10
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.9
21.5
115
447
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
22.4
21.0
30
14
G91.1
ICD-10 Finland
Obstructive hydrocephalus
31.2
20.7
27
9
G91.0
ICD-10 Finland
Communicating hydrocephalus
26.5
20.6
28
11
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
19.6
20.1
30
16
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
19.8
140
626
M03BX01
ATC
baclofen; systemic
6.9
19.7
31
47
H54.7
ICD-10 Finland
Unspecified visual loss
25.5
19.7
27
11
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
47.5
19.3
23
5
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
+∞
18.8
18
*
102
Kela drug reimbursment
Diabetes insipidus
195.4
18.6
19
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
18.6
139
637
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
6.2
18.4
32
54
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
45.4
18.3
22
5
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
18.2
130
583
WX882
NOMESCO Finland
High dependency care
4.3
18.1
49
122
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
7.5
17.9
26
36
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
68.6
17.8
20
*
H54.1
ICD-10 Finland
Severe visual impairment, binocular
184.8
17.6
18
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.6
17.2
28
44
H53.2
ICD-10 Finland
Diplopia
4.7
16.6
39
87
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
16.3
86
330
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
48.8
16.1
19
*
N05BA09
ATC
clobazam; oral
15.0
16.0
26
18
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.7
15.7
51
145
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
17.7
15.7
24
14
N04BB01
ATC
amantadine; oral
12.1
15.7
28
24
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
39.1
15.5
19
5
A06AD11
ATC
lactulose; oral
2.4
15.3
116
531
183
Kela drug reimbursment
Lamotrigin and topiramate
11.2
14.6
27
25
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.5
14.5
51
153
Z2445
NOMESCO Finland
Psychologist
3.4
14.3
53
165
N03AX18
ATC
lacosamide; systemic
14.8
14.1
23
16
H54.3
ICD-10 Finland
Mild or no visual impairment, binocular
30.8
13.9
18
6
N05CD08
ATC
midazolam; nasal, systemic
4.8
13.9
32
70
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.8
13.9
74
285
L03AB07
ATC
interferon beta-1a; parenteral
20.6
13.8
20
10
H54.0
ICD-10 Finland
Blindness, binocular
+∞
13.6
13
*
N03AF01
ATC
carbamazepine; oral, rectal
3.4
13.6
51
160
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
142.8
13.5
14
*
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
142.8
13.5
14
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.8
13.5
73
283
H54.4
ICD-10 Finland
Blindness, monocular
26.4
13.4
18
7
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.3
13.3
109
515
N03AE01
ATC
clonazepam; systemic
3.4
13.0
49
154
L28
ICPC
Limited function/disability (L)
2.2
12.9
127
648
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
12.7
281
1897
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.7
12.6
41
117
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
17.7
12.6
19
11
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
5.2
12.5
26
52
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
5.2
12.5
26
52
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.0
12.5
27
56
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
18.5
12.1
18
10
L03AX13
ATC
glatiramer acetate; parenteral
27.3
12.1
16
6
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
10.3
12.1
23
23
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
12.1
55
194
R35
ICD-10 Finland
Polyuria
2.9
11.9
57
207
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.7
11.7
27
59
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
11.7
110
549
G93.2
ICD-10 Finland
Benign intracranial hypertension
66.2
11.6
13
*
N03AX09
ATC
lamotrigine; oral
3.2
11.6
46
149
H53.1
ICD-10 Finland
Subjective visual disturbances
2.9
11.6
57
210
-, ,
ICD-10 Finland
5.0
11.5
25
52
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
11.5
122
640
34099
ICD-8 Finland
Multiple sclerosis
122.1
11.5
12
*
ZXD05
NOMESCO Finland
Urgent procedure
1.9
11.4
209
1322
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
11.4
302
2135
N05BA01
ATC
diazepam; systemic, rectal
2.2
11.3
102
502
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
17.4
11.2
17
10
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
13.0
11.2
19
15
SPAT1216
SPAT
Assessment of functional ability
2.1
11.0
113
584
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
44.1
10.9
13
*
N03AX11
ATC
topiramate; oral
4.3
10.9
28
67
ZXC95
NOMESCO Finland
Use of surgical navigator
9.1
10.8
22
25
N03AX16
ATC
[U] pregabalin
1.9
10.7
158
931
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
10.6
66
274
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.5
10.6
36
106
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.9
10.6
23
48
E23.05
ICD-10 Finland
Lack of TSH
111.7
10.4
11
*
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
+∞
10.4
10
*
ZXA10
NOMESCO Finland
Bilateral
2.0
10.4
135
760
H01AC01
ATC
somatropin; parenteral
8.4
10.4
22
27
H34.1
ICD-10 Finland
Central retinal artery occlusion
19.1
10.3
15
8
H26.4
ICD-10 Finland
After-cataract
2.5
10.2
69
298
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
13.4
10.2
17
13
N03AB02
ATC
phenytoin; systemic
5.4
10.2
20
38
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
8.6
10.1
21
25
SPAT1234
SPAT
Support of social functional capacity
3.2
10.1
41
135
G04BD07
ATC
tolterodine; oral
3.1
10.0
42
141
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.5
10.0
35
105
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.7
9.9
31
86
XKD00
NOMESCO Finland
Uroflowmetry
2.1
9.8
100
514
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
10.9
9.8
18
17
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
9.8
50
188
D35.30
ICD-10 Finland
Craniopharyngoma
55.8
9.7
11
*
XKC03
NOMESCO Finland
Water cystometry
3.7
9.6
30
83
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.3
9.6
36
113
A28
ICPC
Limited function/disability NOS
2.0
9.5
117
645
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
101.4
9.4
10
*
2132
FHL
Ventricular operators sunt
101.4
9.4
10
*
L04AA27
ATC
[U] fingolimod
101.4
9.4
10
*
L03AB08
ATC
interferon beta-1b; parenteral
30.5
9.4
12
*
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
30.5
9.4
12
*
Z2446
NOMESCO Finland
Social worker
2.4
9.4
65
284
P85
ICPC
Mental retardation
12.6
9.4
16
13
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
+∞
9.4
9
*
3771A
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic atrophy
+∞
9.4
9
*
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
22.1
9.4
13
6
OAB43, ,
SPAT
0.4
9.4
51
1137
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
9.3
210
1400
SPAT1254
SPAT
Administration of medicine
2.0
9.3
105
562
114
Kela drug reimbursment
Glaucoma
2.4
9.1
63
275
G81.9
ICD-10 Finland
Hemiplegia, unspecified
8.5
9.1
19
23
H54.5
ICD-10 Finland
Severe visual impairment, monocular
15.9
9.1
14
9
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
37.2
9.0
11
*
AA1AA
NOMESCO Finland
Head X-ray examination
7.6
9.0
20
27
ZXC86
NOMESCO Finland
Use of endoscopic device
18.9
9.0
13
7
H40.11
ICD-10 Finland
Low pressure glaucoma
4.8
8.9
20
43
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
9.7
8.8
17
18
R51.80
ICD-10 Finland
Headache
1.9
8.8
114
639
Z3231
NOMESCO Finland
Registered nurse
1.7
8.8
195
1290
R32
ICD-10 Finland
Unspecified urinary incontinence
4.0
8.8
25
65
G81.1
ICD-10 Finland
Spastic hemiplegia
50.7
8.7
10
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.4
8.7
64
288
L04AA06
ATC
mycophenolic acid; systemic
4.7
8.6
20
44
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.6
8.6
49
195
L04AX01
ATC
azathioprine; systemic
3.1
8.6
36
121
G91.8
ICD-10 Finland
Other hydrocephalus
27.9
8.5
11
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
7.5
8.5
19
26
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
20.3
8.5
12
6
E22.80
ICD-10 Finland
Central precocious puberty
91.2
8.4
9
*
E23.2
ICD-10 Finland
Diabetes insipidus
91.2
8.4
9
*
H03AA01
ATC
levothyroxine sodium; systemic
1.8
8.4
152
946
H52.1
ICD-10 Finland
Myopia
3.2
8.4
33
107
37790
ICD-8 Finland
Other diseases of retina and optic nerve, Atrophia (et degeneratio) nervi optici (tabica excepta)
+∞
8.3
8
*
H50.1
ICD-10 Finland
Divergent concomitant strabismus
10.9
8.3
15
14
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
8.3
88
459
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.9
8.2
112
638
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
8.2
182
1201
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.6
8.2
19
42
F83
ICD-10 Finland
Mixed specific developmental disorders
7.0
8.1
19
28
G93.0
ICD-10 Finland
Cerebral cysts
33.8
8.1
10
*
164
Kela drug reimbursment
Fingolimod
33.8
8.1
10
*
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
33.8
8.1
10
*
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
10.2
8.1
15
15
ZXA00
NOMESCO Finland
Right side
1.7
8.1
176
1155
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
13.2
7.9
13
10
R4120
NOMESCO Finland
Occupational therapy
2.4
7.9
56
248
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
7.8
99
549
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
8.6
7.8
16
19
PAW37
NOMESCO Finland
Biopsy of temporal artery
11.0
7.8
14
13
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
9.6
7.8
15
16
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
7.8
249
1801
H53.0
ICD-10 Finland
Amblyopia ex anopsia
6.5
7.8
19
30
G04BD09
ATC
trospium; oral
4.0
7.8
22
57
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
6.0
7.7
20
34
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
45.5
7.7
9
*
36703
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris
45.5
7.7
9
*
N18
ICPC
Paralysis/weakness
4.4
7.7
19
44
H25.8
ICD-10 Finland
Other senile cataract
2.2
7.7
69
337
H52.0
ICD-10 Finland
Hypermetropia
3.7
7.6
24
67
R3120
NOMESCO Finland
Training in mobility skills
18.6
7.6
11
6
RD210, ,
NOMESCO Finland
3.9
7.6
22
58
G40.10
ICD-10 Finland
Simple partial seizures
10.2
7.6
14
14
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
7.5
102
580
SPAT1172
SPAT
Guidance concerning hydration
4.5
7.5
18
41
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
81.0
7.4
8
*
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
81.0
7.4
8
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.0
7.4
84
449
A02BC03
ATC
lansoprazole; oral
1.7
7.4
179
1205
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.7
7.3
39
150
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
11.0
7.3
13
12
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.2
7.3
19
46
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
7.3
74
379
74200
ICD-8 Finland
Congenital hydrocephalus, Communicans
+∞
7.3
7
*
C72.3
ICD-10 Finland
Malignant neoplasm: Optic nerve
+∞
7.3
7
*
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
15.9
7.2
11
7
RS222, ,
NOMESCO Finland
7.4
7.2
16
22
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
30.4
7.2
9
*
L04AA31
ATC
[U] teriflunomide
30.4
7.2
9
*
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
30.4
7.2
9
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
6.7
7.1
17
26
RS140, ,
NOMESCO Finland
20.3
7.1
10
5
301
Kela drug reimbursment
Growth hormone
12.2
7.1
12
10
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
7.1
86
470
SPAT1255
SPAT
Intravenous administration of medicine
2.5
7.1
43
177
N30.0
ICD-10 Finland
Acute cystitis
1.9
7.0
100
576
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
7.0
222
1595
Z02.7
ICD-10 Finland
Issue of medical certificate
2.3
7.0
51
229
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.9
7.0
18
31
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.6
6.9
22
62
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.6
6.9
22
62
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
14.0
6.9
11
8
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.3
6.9
51
230
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
3.3
6.9
25
77
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
6.8
176
1201
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
5.8
6.8
18
32
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
40.5
6.8
8
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
6.7
186
1289
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.1
6.7
28
94
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
6.7
226
1642
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
22.8
6.7
9
*
R62.0
ICD-10 Finland
Delayed milestone
5.6
6.6
18
33
XCH05
NOMESCO Finland
Eye pressure longterm registration
7.9
6.6
14
18
CS2P4
NOMESCO Finland
Optic nerve head imaging
7.9
6.6
14
18
R42
ICD-10 Finland
Dizziness and giddiness
1.7
6.6
138
890
G40.89
ICD-10 Finland
Other epilepsy
12.4
6.6
11
9
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
12.4
6.6
11
9
S01EE04
ATC
travoprost; ophthalmic
4.2
6.6
17
41
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
6.6
74
394
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
8.8
6.6
13
15
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
6.6
85
475
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
6.9
6.5
15
22
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
6.5
50
229
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
6.5
62
310
H52.2
ICD-10 Finland
Astigmatism
3.7
6.5
20
55
G40
ICD-10 Finland
Epilepsy
6.3
6.5
16
26
S00.0
ICD-10 Finland
Superficial injury of scalp
3.6
6.5
21
60
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
70.5
6.4
7
*
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
70.5
6.4
7
*
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
70.5
6.4
7
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
6.4
93
539
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.1
6.4
26
86
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
14.5
6.4
10
7
S01ED01
ATC
timolol; ophthalmic
3.2
6.4
25
81
WF099
NOMESCO Finland
Other radiotherapy
11.2
6.3
11
10
7423A
ICD-9 Finland
Other congenital anomalies of nervous system, Congenital hydrocephalus
+∞
6.3
6
*
AAK00
NOMESCO Finland
Cranioplasty
+∞
6.3
6
*
E23.0
ICD-10 Finland
Hypopituitarism
+∞
6.3
6
*
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
+∞
6.3
6
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
26.9
6.2
8
*
353
Kela drug reimbursment
Cladribine and fingolimod
26.9
6.2
8
*
D32.03
ICD-10 Finland
Benign meningioma in ventricles
26.9
6.2
8
*
H02.4
ICD-10 Finland
Ptosis of eyelid
3.2
6.2
24
77
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.0
6.2
17
43
N99
ICPC
Neurological disease other
6.4
6.2
15
24
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.8
6.2
16
28
G04BD04
ATC
oxybutynin; oral, transdermal
2.4
6.2
43
189
S18
ICPC
Laceration/cut
1.5
6.1
279
2155
R50.9
ICD-10 Finland
Fever, unspecified
1.8
6.1
102
616
R4130
NOMESCO Finland
Speech therapy
3.1
6.1
25
83
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.1
6.1
57
283
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
6.1
49
229
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
6.1
234
1744
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
6.0
40
172
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.6
6.0
16
29
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.9
6.0
17
44
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
69
132
5.72
35.12
1.6
1.9
617.63
431.04
mg/l
0.71
64
122
62
118
5.70
31.67
1.4
1.8
3.70
3.68
mmol/l
0.03
57
109
61
118
5.60
30.61
1.9
1.9
23.17
12.41
e6/l
0.25
48
94
61
118
5.60
30.61
1.9
1.9
1328.33
1076.52
e6/l
0.08
48
96
32
29
11.55
30.43
2.2
1.4
—
—
—
0
0
38
51
7.85
26.99
2.0
1.4
—
—
—
0
0
29
37
8.15
21.43
1.0
1.0
—
—
—
0
0
124
535
2.62
18.80
3.7
2.0
378.06
359.93
nmol/l
0.12
115
498
31
50
6.46
18.62
1.0
1.1
—
—
—
0
0
134
603
2.54
18.62
11.6
6.9
—
—
—
0
0
32
58
5.75
17.11
1.1
1.1
—
—
—
0
0
36
73
5.16
17.07
1.2
1.1
—
—
—
0
0
26
40
6.73
16.31
1.1
1.1
246.19
202.68
mg/l
0.78
21
34
25
37
6.98
16.24
2.4
1.6
—
—
—
0
0
350
2431
1.94
15.38
11.0
6.9
1.21
1.22
mmol/l
0.89
324
2235
370
2649
1.91
14.52
10.6
7.4
1.22
1.22
mmol/l
0.05
328
2290
29
56
5.37
14.50
1.1
1.1
—
—
—
0
0
36
84
4.48
14.47
4.7
5.4
458.45
370.84
umol/l
2.01
29
76
243
1543
1.91
13.54
2.7
2.1
181.88
204.60
u/l
0.37
225
1459
51
162
3.33
13.31
2.8
1.7
6.40
9.04
u/l
0.75
38
130
151
818
2.10
13.18
2.3
2.2
29.16
29.60
s
0.46
144
792
26
28
9.62
13.07
1.1
1.0
1.39
1.11
u/l
—
10
16
204
1239
1.94
12.88
2.9
2.3
—
—
—
0
0
412
3124
1.86
12.79
7.8
5.3
6.67
6.64
mmol/l
0.10
399
2923
149
833
2.02
11.82
2.0
1.9
—
—
—
0
0
308
2189
1.77
11.37
6.5
5.1
35.15
35.77
g/l
1.01
285
2043
136
746
2.04
11.33
7.0
6.2
1.04
1.08
mmol/l
0.99
128
692
72
309
2.49
10.83
1.6
1.7
—
—
—
0
0
14
5
28.55
10.76
1.6
1.2
—
—
—
0
0
21
41
5.26
10.37
5.3
3.0
—
—
—
0
0
432
3439
1.75
10.20
7.0
4.3
4724.83
2663.42
e6/l
—
6
48
357
2703
1.70
10.06
8.0
6.5
10.86
12.94
umol/l
2.16
331
2553
147
865
1.90
9.89
5.0
4.1
0.82
0.82
mmol/l
0.27
141
815
281
2039
1.66
8.98
2.1
1.9
95.97
94.41
pmol/l
0.21
160
1065
106
590
1.95
8.33
10.5
9.4
14.02
12.43
kpa
1.78
101
562
265
1924
1.63
8.27
4.6
3.2
—
—
—
0
0
15
15
10.20
8.06
1.1
1.0
1818.07
1256.87
miu/ml
0.74
15
15
105
590
1.93
8.01
1.8
1.8
—
—
—
0
0
476
4010
1.68
7.96
9.7
7.3
83.97
82.04
u/l
0.28
443
3765
393
3158
1.61
7.94
12.9
9.2
4.46
4.03
e9/l
2.45
355
2745
17
22
7.90
7.91
2.9
3.3
28.07
34.25
umol/l
0.66
11
16
146
917
1.76
7.78
3.1
2.9
1.04
0.84
e6/l
0.34
83
516
104
588
1.91
7.78
10.7
9.5
1.06
1.18
mmol/l
0.10
79
468
105
597
1.90
7.72
1.9
1.9
—
—
—
0
0
81
426
2.03
7.45
2.3
2.4
4.02
6.86
ug/l
2.22
66
374
144
913
1.74
7.40
1.8
1.7
1224.01
1206.78
nmol/l
0.08
110
704
474
4053
1.61
6.81
4.9
3.9
14.87
14.72
pmol/l
0.57
426
3693
18
34
5.41
6.50
1.2
1.1
—
—
—
0
0
78
427
1.94
6.40
7.5
5.4
1.90
1.63
mmol/l
0.31
65
312
168
1158
1.61
6.16
7.7
3.8
1.02
1.02
kg/l
0.06
20
171
44
196
2.33
6.13
2.3
2.0
—
—
—
0
0
95
573
1.77
5.74
9.2
5.3
1.87
1.72
mmol/l
0.16
78
464
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
36
4.82
5.64
1.1
1.1
—
—
—
0
0
30
116
2.66
5.63
1.5
1.4
—
—
—
0
0
30
116
2.66
5.63
1.5
1.4
—
—
—
0
0
37
159
2.41
5.60
1.6
1.4
0.11
0.12
iu/ml
—
5
33
87
518
1.78
5.49
2.6
2.6
0.21
0.21
g/l
0.35
82
490
274
2154
1.47
5.32
3.0
2.4
77.94
76.41
nmol/l
0.34
243
1952
73
419
1.84
5.19
4.1
2.2
12.03
12.85
nmol/l
0.43
67
373
590
5448
1.82
5.16
26.4
16.0
139.56
139.65
mmol/l
0.30
577
5304
34
147
2.38
5.09
1.5
1.4
—
—
—
0
0
321
2617
1.44
5.07
9.8
6.0
57.32
55.99
%
1.11
309
2471
163
1163
1.53
5.04
1.6
1.5
19.91
20.46
nmol/l
0.17
140
993
14
28
5.09
4.96
1.1
1.1
—
—
—
0
0
200
1496
1.48
4.92
3.7
3.2
0.31
0.36
e6/l
0.22
154
1136
590
5464
1.79
4.89
26.0
16.0
3.95
3.97
mmol/l
0.95
575
5308
10
13
7.79
4.86
2.1
2.0
25.01
15.68
umol/l
—
10
13
27
107
2.59
4.85
1.7
1.4
—
—
—
0
0
56
302
1.93
4.82
1.6
1.4
—
—
—
0
0
322
2647
1.43
4.75
10.4
6.2
28.05
28.87
%
0.61
310
2501
313
2581
1.41
4.44
6.0
3.6
0.00
0.00
estimate
0.50
41
510
289
2355
1.41
4.37
16.1
13.4
1.21
1.23
inr
0.13
47
674
38
185
2.12
4.34
2.1
1.8
—
—
—
0
0
55
307
1.86
4.29
2.4
3.4
4.34
4.66
pmol/l
0.91
49
277
95
622
1.62
4.22
4.4
4.2
31.10
31.45
%
0.11
68
425
534
4877
1.51
4.08
5.2
4.6
1.91
2.14
mu/l
0.46
479
4480
173
1299
1.45
4.07
2.6
2.2
3.35
3.04
mg/l
1.02
145
1116
292
2413
1.38
3.94
3.1
2.6
—
—
—
0
0
575
5358
1.59
3.78
22.0
13.8
28.07
22.85
mg/l
2.16
474
4162
311
2609
1.37
3.77
6.1
3.6
0.00
0.01
estimate
0.80
40
468
65
402
1.68
3.61
2.4
2.6
70.96
66.99
ml/min/173m2
0.32
27
166
11
26
4.28
3.52
1.2
1.1
—
—
—
0
0
11
26
4.28
3.52
6.2
2.8
43718.18
36546.35
ug/l
0.56
11
26
238
1931
1.36
3.50
4.1
3.6
76.97
37.29
ng/l
0.59
189
1323
306
2582
1.35
3.48
7.5
4.9
0.00
0.00
estimate
0.50
38
482
177
1374
1.39
3.40
7.3
3.9
0.00
0.00
estimate
0.50
37
473
9
18
5.05
3.38
4.6
2.1
—
—
—
0
0
18
71
2.58
3.32
1.2
1.3
—
—
—
0
0
31
156
2.04
3.30
3.4
3.1
—
—
—
0
0
34
612
0.53
3.29
1.5
2.1
—
—
—
0
0
146
1104
1.41
3.25
3.1
2.6
4.84
5.00
e6/l
0.07
136
1000
37
200
1.90
3.23
1.6
2.1
1.58
1.51
g/l
0.15
32
175
120
883
1.44
3.10
3.2
3.0
2.49
1.80
e6/l
0.43
56
486
64
412
1.61
3.07
5.2
4.5
86.51
79.35
ng/l
0.23
58
378
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
31
161
1.97
3.04
3.4
3.2
0.39
0.36
u/ml
0.18
18
94
100
717
1.47
2.95
2.5
2.5
21.20
22.18
%
0.25
87
615
215
1762
1.33
2.85
3.4
3.5
2.36
2.36
mmol/l
0.18
178
1559
10
28
3.61
2.79
2.6
1.7
201.20
116.70
ng/l
—
10
22
201
1636
1.33
2.79
4.0
3.3
325.00
85.16
e6/l
0.39
154
1264
31
544
0.55
2.77
1.5
2.0
—
—
—
0
0
110
815
1.42
2.73
2.5
2.5
12.27
13.18
umol/l
0.61
96
755
181
1456
1.34
2.71
3.4
3.2
1189.45
1301.01
ng/l
0.20
155
1229
6
10
6.04
2.70
1.2
1.3
—
—
—
0
0
10
29
3.49
2.70
1.1
1.0
—
—
—
0
0
103
756
1.43
2.69
2.5
2.5
2.23
2.37
g/l
1.36
89
697
32
176
1.86
2.69
1.6
1.6
—
—
—
0
0
11
35
3.18
2.65
2.5
2.6
—
—
—
0
0
5
7
7.19
2.55
2.2
3.4
—
—
—
0
0
10
31
3.26
2.52
1.3
1.2
—
—
—
0
0
57
377
1.56
2.48
2.0
1.6
—
—
—
0
0
195
1604
1.31
2.47
2.7
2.5
53.76
60.30
u/l
0.71
177
1488
8
21
3.84
2.47
2.4
2.4
112.88
99.73
ug/l
—
8
21
6
12
5.03
2.40
1.2
1.3
—
—
—
0
0
18
84
2.18
2.36
1.3
1.2
2.83
4.40
u/ml
—
6
35
7
17
4.15
2.36
1.1
1.2
—
—
—
0
0
10
33
3.06
2.36
1.8
1.5
—
—
—
0
0
592
5657
1.48
2.31
15.1
10.1
27.57
26.58
u/l
0.35
571
5473
14
59
2.40
2.30
1.5
1.9
—
—
—
0
0
13
53
2.48
2.29
2.5
3.1
3.70
6.91
nmol/l
0.49
13
53
27
464
0.56
2.27
1.4
1.7
—
—
—
0
0
120
932
1.35
2.25
3.3
2.9
2.47
2.45
mmol/l
1.15
100
814
17
81
2.13
2.14
1.3
1.2
5.83
4.61
u/ml
—
6
23
25
138
1.84
2.12
2.2
1.9
—
—
—
0
0
9
209
0.42
2.10
1.3
1.5
—
—
—
0
0
28
161
1.77
2.09
1.4
1.4
327.29
300.22
ug/g
0.21
13
97
69
497
1.43
2.03
3.9
2.3
32.08
137.39
u/l
0.55
60
419
19
97
1.99
2.02
2.1
2.0
—
—
—
0
0
7
21
3.36
1.97
1.1
1.3
—
—
—
0
0
5
11
4.57
1.94
2.0
1.7
—
—
—
0
0
6
16
3.77
1.94
1.0
1.1
—
—
—
0
0
6
16
3.77
1.94
1.0
1.1
—
—
—
0
0
16
78
2.08
1.92
1.1
1.1
—
—
—
0
0
25
143
1.78
1.91
1.8
1.9
—
—
—
0
0
425
3918
1.24
1.89
4.7
4.1
12.77
11.55
mm/h
0.96
395
3628
12
52
2.33
1.88
3.1
2.4
—
—
—
0
0
6
17
3.55
1.84
1.2
1.1
—
—
—
0
0
37
239
1.58
1.83
3.0
1.5
18.26
25.74
iu/l
0.74
32
200
12
53
2.29
1.81
2.0
1.2
—
—
—
0
0
20
109
1.86
1.79
1.9
1.9
—
—
—
0
0
20
109
1.86
1.79
1.9
1.9
—
—
—
0
0
204
1748
1.24
1.79
5.0
3.4
41.87
32.05
u/l
0.76
191
1664
20
112
1.81
1.66
10.1
8.1
1208.22
225.77
iu/ml
—
9
22
14
69
2.05
1.65
1.1
2.3
—
1680.00
—
0
5
227
1989
1.22
1.58
6.8
3.7
—
—
—
0
0
24
145
1.68
1.56
1.3
1.2
—
28.54
—
0
5
137
1146
1.25
1.48
2.0
1.8
1.34
1.21
mg/l
0.22
98
872
10
45
2.24
1.47
7.5
2.7
55.60
39.48
%
—
10
24
9
39
2.33
1.43
1.1
1.2
—
—
—
0
0
9
40
2.27
1.40
1.1
1.3
—
—
—
0
0
9
40
2.27
1.40
1.0
1.2
—
—
—
0
0
14
74
1.91
1.40
1.4
1.6
—
—
—
0
0
85
1055
0.78
1.38
1.5
1.6
—
—
—
0
0
10
196
0.50
1.37
3.4
1.9
—
—
—
0
0
5
17
2.96
1.36
1.2
1.1
—
—
—
0
0
9
43
2.11
1.30
1.0
1.2
—
81.83
—
0
6
79
628
1.29
1.30
6.2
3.0
6.73
8.02
umol/l
0.56
70
545
14
77
1.84
1.26
1.4
1.8
—
—
—
0
0
14
77
1.84
1.26
1.4
1.8
—
—
—
0
0
25
163
1.55
1.25
1.8
1.2
—
—
—
0
0
6
25
2.41
1.24
3.0
2.2
—
—
—
0
0
6
25
2.41
1.24
3.0
2.2
—
—
—
0
0
14
78
1.81
1.22
2.6
1.9
—
—
—
0
0
6
26
2.32
1.19
4.2
2.7
373.17
684.92
u/ml
—
6
26
6
26
2.32
1.19
3.2
2.2
—
—
—
0
0
18
110
1.65
1.16
1.0
1.2
—
2.24
—
0
9
0
34
0.00
1.16
0.0
2.1
—
150.80
—
0
5
13
72
1.82
1.15
1.2
1.8
—
—
—
0
0
0
35
0.00
1.15
0.0
7.7
—
37.67
—
0
12
21
135
1.57
1.12
1.3
1.7
—
—
—
0
0
172
1513
1.19
1.12
3.8
3.8
9.59
9.69
mg/mmol
0.01
104
951
5
21
2.39
1.09
1.0
1.1
14.10
8.82
ug/l
—
5
21
7
32
2.20
1.08
2.1
3.9
99.86
90.22
%
—
7
32
6
123
0.48
1.06
1.3
1.5
—
—
—
0
0
14
82
1.72
1.06
1.5
1.7
—
—
—
0
0
373
3496
1.16
1.06
5.2
3.2
60.59
47.76
u/l
1.50
347
3281
24
162
1.50
1.05
1.4
1.2
—
—
—
0
0
12
67
1.81
1.05
2.4
2.0
—
—
—
0
0
5
22
2.28
1.03
3.6
2.5
—
—
—
0
0
504
4840
1.18
1.01
17.7
12.6
84.52
82.24
ml/min/173m2
1.28
428
3982
24
164
1.48
1.00
1.4
1.2
—
—
—
0
0
5
23
2.18
0.98
1.0
1.9
—
—
—
0
0
20
132
1.53
0.98
2.4
1.8
2.68
5.72
iu/l
—
5
41
18
116
1.57
0.97
2.7
1.7
—
—
—
0
0
250
2288
1.15
0.97
3.2
2.7
132.93
121.52
ug/l
0.34
221
2125
11
62
1.79
0.94
1.5
1.3
0.45
0.58
nmol/l
1.01
11
56
176
1574
1.16
0.93
4.4
4.6
1.72
2.26
ug/l
1.32
154
1419
179
1606
1.16
0.91
3.3
3.4
7.15
7.64
mmol/l
0.85
152
1364
21
144
1.47
0.88
1.7
1.6
—
—
—
0
0
521
5038
1.17
0.85
5.0
4.4
5.81
5.94
mmol/l
1.62
469
4619
46
364
1.28
0.84
1.3
1.2
121.01
166.12
iu/ml
0.32
19
147
6
113
0.53
0.83
1.3
1.4
—
—
—
0
0
6
113
0.53
0.83
1.3
1.4
—
—
—
0
0
6
113
0.53
0.83
1.3
1.4
—
—
—
0
0
6
113
0.53
0.83
1.3
1.4
—
—
—
0
0
8
47
1.71
0.81
1.0
1.2
—
84.29
—
0
7
17
114
1.50
0.80
1.1
1.2
—
—
—
0
0
0
26
0.00
0.78
0.0
1.7
—
7.52
—
0
26
13
82
1.60
0.78
1.2
1.7
—
—
—
0
0
87
747
1.19
0.77
1.5
1.4
—
—
—
0
0
16
107
1.51
0.76
2.1
2.1
137.00
132.42
g/l
—
7
81
23
166
1.40
0.76
2.6
2.3
14900.94
3860.56
u/l
—
5
65
6
34
1.77
0.76
3.0
1.9
—
—
—
0
0
6
34
1.77
0.76
3.0
1.9
—
—
—
0
0
15
99
1.53
0.76
1.5
1.7
—
—
—
0
0
10
59
1.71
0.76
2.7
3.6
—
—
—
0
0
42
334
1.28
0.75
7.8
4.8
130.64
127.95
g/l
0.37
42
329
5
24
2.09
0.74
1.0
1.8
—
—
—
0
0
22
159
1.40
0.73
1.0
1.1
—
—
—
0
0
5
25
2.01
0.73
1.4
1.1
57.00
103.40
u/l
—
5
25
5
25
2.01
0.73
1.4
1.1
9.40
38.35
u/l
—
5
25
7
39
1.80
0.72
1.9
1.3
—
—
—
0
0
608
5975
1.24
0.72
33.0
20.4
39.75
40.27
%
1.33
574
5618
608
5976
1.24
0.71
32.4
20.1
257.26
251.70
e9/l
1.07
593
5817
7
41
1.71
0.70
1.0
1.1
—
—
—
0
0
7
41
1.71
0.70
1.0
1.1
—
—
—
0
0
33
257
1.30
0.70
7.9
4.5
24.65
24.96
mmol/l
0.16
33
250
5
27
1.86
0.68
1.0
1.8
—
—
—
0
0
608
5979
1.23
0.68
32.4
20.1
4.45
4.52
e12/l
2.64
593
5806
18
127
1.43
0.68
4.3
1.6
0.00
0.00
g/l
-0.00
18
118
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
5
28
1.79
0.66
1.6
1.3
—
—
—
0
0
5
28
1.79
0.66
1.6
1.3
—
—
—
0
0
5
28
1.79
0.66
6.2
3.0
—
88572.60
—
0
5
608
5982
1.22
0.66
32.6
20.3
133.12
135.61
g/l
3.85
599
5898
110
977
1.15
0.65
3.6
3.9
644.19
430.36
ng/l
0.18
81
753
18
129
1.41
0.64
4.3
1.6
0.00
0.00
g/l
-0.00
18
119
5
29
1.73
0.64
9.8
3.2
—
—
—
0
0
5
29
1.73
0.64
1.0
2.1
—
—
—
0
0
5
29
1.73
0.64
1.0
2.1
—
—
—
0
0
19
138
1.39
0.63
4.1
1.6
0.06
0.04
g/l
0.13
19
128
8
51
1.58
0.60
1.4
1.2
—
—
—
0
0
8
52
1.54
0.59
1.1
1.0
—
—
—
0
0
19
140
1.37
0.59
1.4
1.4
—
—
—
0
0
6
35
1.72
0.58
1.3
1.8
—
—
—
0
0
9
60
1.51
0.54
2.4
1.8
—
—
—
0
0
9
60
1.51
0.54
2.4
1.8
—
—
—
0
0
9
60
1.51
0.54
2.4
1.8
—
—
—
0
0
24
305
0.78
0.54
2.3
1.9
—
—
—
0
0
462
4735
0.92
0.44
23.9
16.6
15.87
14.69
%
3.05
456
4674
7
51
1.38
0.44
2.4
1.8
—
—
—
0
0
140
1299
1.10
0.43
1.3
1.3
0.89
1.93
u/ml
1.45
27
321
22
176
1.26
0.42
3.7
1.6
—
—
—
0
0
8
57
1.41
0.42
1.5
1.4
—
—
—
0
0
13
96
1.36
0.42
2.2
2.4
17.62
16.52
%
—
5
48
5
33
1.52
0.41
1.4
1.8
13.92
12.63
umol/l
—
5
33
5
33
1.52
0.41
1.6
1.3
—
—
—
0
0
5
33
1.52
0.41
1.6
1.3
—
—
—
0
0
5
34
1.47
0.40
1.2
1.4
0.72
1.05
g/l
—
5
34
26
313
0.82
0.39
1.0
1.0
—
—
—
0
0
22
178
1.24
0.39
1.2
2.0
—
—
—
0
0
17
133
1.29
0.39
1.5
1.5
241.25
278.47
u/ml
0.25
12
64
112
1036
1.10
0.37
1.8
1.7
464.22
5767454.82
pmol/l
0.50
93
867
500
5095
0.92
0.37
4.7
4.3
1.41
1.46
mmol/l
1.81
455
4719
6
46
1.31
0.33
1.0
1.3
—
—
—
0
0
79
859
0.91
0.32
1.2
1.3
5.48
11.56
u/ml
1.09
25
350
7
53
1.32
0.31
2.4
2.1
—
—
—
0
0
19
157
1.22
0.30
1.4
1.3
—
—
—
0
0
132
1247
1.07
0.28
3.9
4.1
21.70
20.91
%
0.20
55
553
8
63
1.27
0.28
1.0
1.2
—
—
—
0
0
20
236
0.84
0.27
2.3
1.9
—
—
—
0
0
87
927
0.93
0.24
2.8
2.9
0.70
0.73
ug/l
0.13
59
596
7
95
0.73
0.22
1.6
1.3
—
—
—
0
0
484
4773
1.05
0.22
6.2
5.5
39.50
39.72
mmol/mol
0.19
444
4459
16
135
1.19
0.21
1.7
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
32.29
—
0
6
0
11
0.00
0.21
0.0
1.0
—
1.73
—
0
6
0
10
0.00
0.21
0.0
1.0
—
27.34
—
0
10
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
6
50
1.20
0.19
1.0
1.6
—
—
—
0
0
31
283
1.10
0.16
1.5
1.3
—
—
—
0
0
14
121
1.16
0.15
1.0
1.2
0.28
3.55
u/ml
—
5
80
136
1405
0.96
0.14
1.6
1.7
1.45
1.40
mmol/l
0.19
117
1194
9
106
0.85
0.13
1.4
1.9
—
—
—
0
0
49
514
0.95
0.10
4.1
3.3
—
—
—
0
0
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
64
664
0.96
0.09
2.1
1.8
1.53
1.48
%
0.20
53
591
6
54
1.11
0.09
2.7
2.2
19.22
16.73
ug/l
—
6
54
353
3562
0.98
0.07
3.2
3.2
—
—
—
0
0
7
83
0.84
0.07
1.3
1.1
—
—
—
0
0
90
880
1.03
0.06
1.2
1.3
46.58
34.85
iu/ml
0.18
17
293
494
4917
1.02
0.06
4.3
3.9
1.40
1.29
mmol/l
2.55
447
4525
38
395
0.96
0.05
3.0
3.4
348.97
216.87
ng/l
0.46
38
357
515
5130
1.02
0.05
4.7
4.3
4.57
4.66
mmol/l
1.12
471
4777
11
120
0.92
0.05
1.6
1.4
—
—
—
0
0
134
1321
1.02
0.05
3.3
2.7
331.73
6057.91
umol/l
4.63
115
1160
15
140
1.07
0.04
1.2
1.4
—
—
—
0
0
10
91
1.10
0.04
1.9
4.2
123.41
350.42
u/ml
—
10
85
12
111
1.08
0.04
1.9
1.5
—
—
—
0
0
14
131
1.07
0.03
1.8
2.4
63.00
66.89
ug/min
—
8
76
29
280
1.04
0.03
3.4
2.8
0.05
0.11
e6/l
1.22
29
272
16
169
0.95
0.03
1.3
1.3
—
—
—
0
0
13
123
1.06
0.01
1.1
1.3
—
—
—
0
0
521
5215
1.00
0.00
5.1
4.8
2.72
2.76
mmol/l
0.46
475
4827
51
507
1.01
0.00
3.7
4.5
186.20
34.04
ug/l
0.40
40
423
7
69
1.01
0.00
2.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
9.3
—
—
—
0
0
7
69
1.01
0.00
2.0
1.6
—
—
—
0
0
7
69
1.01
0.00
2.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
9.0
—
—
—
0
0
7
71
0.99
-0.00
2.0
1.5
—
—
—
0
0
7
70
1.00
-0.00
2.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
100.43
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
9
96
0.94
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
-0.00
2.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
90
1.00
-0.00
6.7
3.3
52.67
56.72
%
—
9
90
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: H7_OPTIC_ATROPHY – Optic atrophy
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).